Citryll Bv
Clinical trials sponsored by Citryll Bv, explained in plain language.
-
New hope for arthritis sufferers: CIT-013 trial launches
Disease control Recruiting nowThis study tests whether CIT-013 can reduce disease activity in adults with moderately active rheumatoid arthritis. About 88 participants will receive either CIT-013 or a placebo every other week for 6 weeks. Researchers will monitor symptoms and side effects to see if the drug i…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for painful skin condition: CIT-013 enters phase 2 trial
Disease control Recruiting nowThis study tests whether CIT-013 can reduce disease activity in adults with hidradenitis suppurativa, a painful skin condition. About 96 participants will receive either 50 mg, 100 mg, or a placebo every two weeks for 12 weeks. Researchers will compare symptom improvement and tra…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New imaging study tracks arthritis Drug's journey inside the body
Knowledge-focused Recruiting nowThis study uses special PET-CT scans to track a new drug called CIT-013 in people with rheumatoid arthritis. The drug aims to calm inflammation caused by immune cells. By seeing where the drug goes, researchers hope to learn how well it reaches affected tissues. About 12 adults a…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC